RJ Hamster
20 Stocks to Sell Now
Hello –
Today, we’re inviting you to take a free look at MarketBeat’s proprietary, up-to-the-minute list of 20 stocks that Wall Street’s top-rated analysts hate.
These aren’t mild downgrades or lukewarm opinions.
These are true Strong Sell stocks.
Some of them may look fine on the surface. A few even have what appear to be solid fundamentals. But when analysts issue a rare Sell rating, it’s usually because something beneath the surface is deeply wrong.
Sell-side analysts may not nail every Buy call… but when they raise red flags, they’re almost always worth listening to.
If any of these stocks are lurking around in your portfolio, you may seriously want to consider dumping them.
Click here to see the list now.
Stay one step ahead,
Matthew Paulson
Founder & CEO, MarketBeat
P.S. Access to 20 Stocks to Sell Now is completely free. Don’t miss your chance to review these timely, high-conviction warnings before the market reacts.
More Reading from MarketBeat
3 Stocks That Could Be Next to Announce a Stock Split
Written by Chris Markoch. Published: 3/15/2026.
Key Points
- Stock splits often follow strong periods of growth and rising share prices.
- KLA, Eli Lilly, and McKesson all trade near or above $900 per share, putting them on investors’ split watch lists.
- Strong fundamentals and bullish analyst outlooks could keep these stocks climbing in 2026.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Stock splits are actions taken by corporations to make their shares nominally more affordable for a broader set of retail investors. They most often follow periods of significant growth or innovation.
Why do stock splits capture investors’ imaginations? The intrinsic value of the company doesn’t change, but investor psychology can strongly influence a stock’s short-term performance. It can be hard for retail investors to consider buying a share trading at $500 or $1,000.
Ground-zero (Ad)
San Francisco is the strangest city in America right now—you can hop into a self-driving car and be chauffeured by a robot, but out the window you see addicts slumped in doorways, open-air drug markets, the mentally ill screaming at the sky, and entire city blocks consumed by homeless encampments. It’s ground-zero for the most disruptive technological forces of our age, and Erez lives in the Bay Area plugged into the capital, the connections, and the companies reshaping the world—the advancements in AI, blockchain, computing, and biosciences are unlike anything the world has seen before, and a tsunami of disruption is coming for everything all at once. During our most recent broadcast, we exposed what we’re calling the most asymmetric opportunity of our careers: an overlooked financial company hiding a multi-billion-dollar blockchain asset Wall Street hasn’t priced in—it’s one of those rare situations Warren Buffett would describe as raining gold when all you have to do is step outside if you want to get rich.Watch the broadcast before the window closes now
Investors with limited capital may find lower-priced shares more accessible because they can buy more of them. Still, stocks with strong share-price growth typically have solid fundamentals behind them.
For example, Costco Wholesale Corp. (NASDAQ: COST) has appeared on many analysts’ lists of companies that could potentially split their stock for years. As of this writing, COST trades just above $1,000 per share. That’s expensive, but the stock has delivered share-price growth of more than 200% over the last five years. Investors who avoided it at $500 missed that gain, which is in addition to the company’s dividend.
By contrast, Walmart Inc. (NASDAQ: WMT)announced a stock split in January 2024. The stock has continued to perform, climbing more than 45% in the past 12 months and over 175% in the last five years, excluding dividends.
The takeaway is that quality matters. Owning companies with strong growth can make a stock split an added benefit, not a gimmick. Here are three companies that could split their stock in 2026.
Semiconductor Leader KLA Approaches $1,400 Per Share
KLA (NASDAQ: KLAC) designs and manufactures equipment, software, and services used by chipmakers for process control and yield management. KLAC stock has jumped more than 375% in the last five years and rose over 100% in 2025.
Even with the stock trading above $1,400 per share, it’s still roughly 13% below its consensus price target of about $1,600. After a strong run as part of the artificial intelligence trade, a stock split could be on the table.
KLA held an Investor Day on March 12, where the company announced several shareholder-friendly actions, including a $7 billion share-repurchase program and a 21% increase to its dividend—the 17th consecutive year it has raised the payout.
A company can announce a stock split at any time, and KLA reports its Q3 earnings for fiscal 2026 on April 29. After the Investor Day announcements, the board may prefer to wait, but with the share price above $1,400, investors will keep wondering when a split might come.
Eli Lilly’s GLP-1 Leadership Keeps the Growth Story Strong
Eli Lilly & Co. (NYSE: LLY) isn’t part of the technology sector, but the stock has behaved like a growth tech name. LLY is up more than 350% over the last five years. That said, the stock has been leveling off recently: it rose about 18% in 2025 and was down roughly 9% through March 12.
LLY trades just under $1,000 as of this writing, and analysts’ consensus price targetsuggests roughly 25% upside. That outlook is supported by expected earnings growth of about 35% over the next 12 months.
But it’s the reason behind the growth that fuels split speculation. Eli Lilly is the market leader in GLP-1 treatments for weight loss by a wide margin, and that lead could widen if the U.S. Food & Drug Administration approves its oral GLP-1 candidate in 2026.
That potential milestone might lead the company to take a wait-and-see approach on a split. Shareholders also recently received a meaningful benefit: a 15.3% dividend increase announced in December 2025.
McKesson’s Quiet Rally Pushes the Stock Near $1,000
McKesson Corp. (NYSE: MCK) is a leading healthcare distribution company that delivers medicines and medical supplies to hospitals, pharmacies, and doctors’ offices nationwide, helping ensure patients receive needed care.
MCK is up more than 400% over the last five years and about 47% in the past 12 months, including a roughly 15% gain so far in 2026 through March 12.
In its most recent earnings report, management raised guidance for FY2026 to call for 12%–16% revenue growth and 17%–19% growth in adjusted earnings per share—the latter well above analysts’ projection of about 11%.
The MCK share price sits above $900 and is approaching the top of its 52-week range. Unlike the other names on this list, McKesson is trading largely in line with its consensus price target.
Still, analyst sentiment remains generally bullish, with several price targets above $1,000. That includes JPMorgan Chase & Co., which carries the highest target at $1,107.
Thank you for subscribing to MarketBeat!
We empower investors to make better financial decisions by providing real-time financial information and independent investment analysis.
If you need assistance with your subscription, don’t hesitate to contact our U.S. based support team at contact@marketbeat.com.
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribefrom these emails.
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103. U.S.A..
